STING in Kidney Disease: A Modulator, Not a Master Switch
Recent research in The American Journal of Pathology refines our understanding of the stimulator of interferon genes (STING) pathway in renal pathology. While elevated STING levels are observed in both human and mouse kidney disease, new genetic deletion studies suggest its role is more nuanced than previously thought. The investigation, which examined the effects of removing STING from kidney tubule cells, myeloid cells, and globally, indicates that STING acts as a fine-tuner of inflammation rather than a primary driver. This challenges the notion of STING as a sole regulator and highlights its complex, context-dependent functions within the intricate landscape of kidney inflammation.
Why it might matter to you: For pathologists focused on inflammation and tissue morphology, this study underscores the importance of precise molecular characterization in diagnostic and research contexts. It suggests that therapeutic strategies targeting STING for kidney disease may require a more tailored approach, considering its modulatory rather than central role. This shift in understanding could influence how you interpret immunohistochemistry (IHC) findings related to inflammatory pathways and assess potential biomarkers for disease progression.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.